Shanghai Pioneer Holding Ltd (HKG:1345)

Market Cap	2.72B -0.5%
Revenue (ttm)	1.49B -17.4%
Net Income	113.95M -33.7%
EPS	0.10 -29.7%
Shares Out	1.16B
PE Ratio	23.94
Forward PE	n/a
Dividend	0.13 (5.72%)
Ex-Dividend Date	n/a

Volume	121,000
Average Volume	62,409
Open	2.350
Previous Close	2.350
Day's Range	2.340 - 2.350
52-Week Range	1.590 - 2.400
Beta	-0.19
RSI	58.68
Earnings Date	Mar 26, 2026

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, dental devices, and imported in...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 343
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1345

Financial Performance

In 2024, Shanghai Pioneer Holding's revenue was 1.53 billion, a decrease of -2.27% compared to the previous year's 1.57 billion. Earnings were 151.62 million, an increase of 9.46%.

Financial numbers in CNY